BEIGF
Price
$15.14
Change
+$1.12 (+7.99%)
Updated
Jan 14 closing price
Capitalization
25.5B
CING
Price
$4.52
Change
-$0.22 (-4.64%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
15.23M
Ad is loading...

BEIGF vs CING

Header iconBEIGF vs CING Comparison
Open Charts BEIGF vs CINGBanner chart's image
BeiGene
Price$15.14
Change+$1.12 (+7.99%)
Volume$100
Capitalization25.5B
Cingulate
Price$4.52
Change-$0.22 (-4.64%)
Volume$126
Capitalization15.23M
BEIGF vs CING Comparison Chart
Loading...
BEIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEIGF vs. CING commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEIGF is a Hold and CING is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (BEIGF: $15.14 vs. CING: $4.55)
Brand notoriety: BEIGF and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEIGF: 87% vs. CING: 186%
Market capitalization -- BEIGF: $25.5B vs. CING: $15.23M
BEIGF [@Biotechnology] is valued at $25.5B. CING’s [@Biotechnology] market capitalization is $15.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEIGF’s FA Score shows that 0 FA rating(s) are green whileCING’s FA Score has 1 green FA rating(s).

  • BEIGF’s FA Score: 0 green, 5 red.
  • CING’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEIGF and CING are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEIGF’s TA Score shows that 1 TA indicator(s) are bullish while CING’s TA Score has 3 bullish TA indicator(s).

  • BEIGF’s TA Score: 1 bullish, 0 bearish.
  • CING’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEIGF is a better buy in the short-term than CING.

Price Growth

BEIGF (@Biotechnology) experienced а 0.00% price change this week, while CING (@Biotechnology) price change was -10.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.11%. For the same industry, the average monthly price growth was +1.05%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

CING is expected to report earnings on Mar 08, 2024.

Industries' Descriptions

@Biotechnology (-1.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEIGF($25.5B) has a higher market cap than CING($15.2M). BEIGF YTD gains are higher at: 7.989 vs. CING (-7.708). CING has higher annual earnings (EBITDA): -15.57M vs. BEIGF (-727.23M). BEIGF has more cash in the bank: 2.7B vs. CING (10M). CING has less debt than BEIGF: CING (234K) vs BEIGF (1.1B). BEIGF has higher revenues than CING: BEIGF (3.32B) vs CING (0).
BEIGFCINGBEIGF / CING
Capitalization25.5B15.2M167,763%
EBITDA-727.23M-15.57M4,671%
Gain YTD7.989-7.708-104%
P/E RatioN/AN/A-
Revenue3.32B0-
Total Cash2.7B10M27,020%
Total Debt1.1B234K470,513%
TECHNICAL ANALYSIS
Technical Analysis
BEIGFCING
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 24 days ago
67%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 24 days ago
19%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 24 days ago
19%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
BEIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOMH3.581.31
+57.71%
Dominari Holdings
KNOP5.600.08
+1.45%
Knot Offshore Partners LP
CRBG34.11-0.02
-0.06%
Corebridge Financial
SPT33.10-0.53
-1.58%
Sprout Social
PUMP9.20-0.15
-1.60%
ProPetro Holding Corp

BEIGF and

Correlation & Price change

A.I.dvisor tells us that BEIGF and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEIGF and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEIGF
1D Price
Change %
BEIGF100%
N/A
GOVX - BEIGF
29%
Poorly correlated
+3.72%
CING - BEIGF
29%
Poorly correlated
-4.01%
CMRX - BEIGF
27%
Poorly correlated
+0.98%
POLBF - BEIGF
25%
Poorly correlated
N/A
TSVT - BEIGF
11%
Poorly correlated
+5.22%
More

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with GOVX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-4.01%
GOVX - CING
34%
Loosely correlated
+3.72%
BEIGF - CING
29%
Poorly correlated
N/A
ELVN - CING
29%
Poorly correlated
+1.97%
SLNO - CING
28%
Poorly correlated
+0.97%
SNBIF - CING
28%
Poorly correlated
N/A
More